Iron deficiency in pulmonary arterial hypertension: prevalence and potential usefulness of oral supplementation.

Conclusions: Iron deficiency is highly prevalent in patients with PAH and is associated with worse clinical conditions. Treatment with oral liposomal iron is a therapeutic option which should be further investigated in future trials. PMID: 31902301 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31902301?dopt=Abstract

Source: Acta Cardiologica - January 8, 2020 Category: Cardiology Tags: Acta Cardiol Source Type: research